Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bruce Daugherty Insider Profile
4 Followers
Bruce Daugherty, Senior Director of Drug Development and Secretary at Tonix Pharma, holds 57.77K shares in Tonix Pharma (Ticker: TNXP). Most recently, Bruce Daugherty Bought $100,000 shares of Tonix Pharma on Jun 21, 2016 for an estimated value of 200.00K.
Bruce Daugherty has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bruce Daugherty's holdings
Insider Roles
Senior Director of Drug Development and Secretary
Roles that Bruce Daugherty holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bruce Daugherty
Bruce Daugherty's Trading History
List of latest transactions for each holding click on a transaction to see Bruce Daugherty's performance on stock
You May Also Like
Bruce Daugherty insider profile FAQ
What is the percentage of profitable transactions made by Bruce Daugherty?
The percentage of profitable transactions made by Bruce Daugherty is ―.
What is the average return per transaction made by Bruce Daugherty?
The average return per transaction made by Bruce Daugherty is ―.
What stocks does Bruce Daugherty hold?
Bruce Daugherty holds: TNXP stocks.
What was Bruce Daugherty’s latest transaction?
Bruce Daugherty latest transaction was an Informative Buy of $200.00K.
What was Bruce Daugherty's most profitable transaction?
Bruce Daugherty’s most profitable transaction was an Informative Buy of TNXP stock on June 21, 2016. The return on the trade was -79.20%.
What is Bruce Daugherty's role in Tonix Pharma?
Bruce Daugherty's role in Tonix Pharma is Senior Director of Drug Development and Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.